{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965300",
  "id": "02965300",
  "pages": 7,
  "price_sensitive": false,
  "date": "20250702",
  "time": "1753",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250702/pdf/06ldgpn0sw507v.pdf",
  "summary": "### **Material Information Summary (Form 605 \u2013 Ceasing to be a Substantial Holder)**  \n\n- **Substantial Holder**: Mitsubishi UFJ Financial Group, Inc. ceased to be a substantial holder in **Mayne Pharma Group Limited** (ASX: MYX) on **1 July 2025**.  \n- **Key Transactions**:  \n  - **Total Shares Sold**: ~94,400 shares (via Morgan Stanley and First Sentier Investors).  \n  - **Notable Sale**: Single block of **68,988 shares** sold by First Sentier on 27 June 2025.  \n  - **Net Impact**: Reduction in Mitsubishi UFJ's holdings below substantial holding threshold (previously **5%+**).  \n\n**Rationale for Materiality**: Large-scale disposals may signal institutional sentiment shifts or strategic exits, influencing liquidity and trading dynamics.",
  "usage": {
    "prompt_tokens": 6967,
    "completion_tokens": 180,
    "total_tokens": 7147,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-02T08:04:55.507127"
}